BioLineRx Ltd. (BLRX)
2.216
+0.01
(+0.27%)
USD |
NASDAQ |
Oct 09, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Net Income (Quarterly) : -4.414M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.414M |
| March 31, 2026 | -2.581M |
| December 31, 2025 | -2.25M |
| September 30, 2025 | -0.9816M |
| June 30, 2025 | -4.025M |
| March 31, 2025 | 5.100M |
| December 31, 2024 | -3.212M |
| September 30, 2024 | -5.822M |
| June 30, 2024 | 0.484M |
| March 31, 2024 | -0.696M |
| December 31, 2023 | -13.88M |
| September 30, 2023 | -16.02M |
| June 30, 2023 | -18.54M |
| March 31, 2023 | -12.16M |
| December 31, 2022 | -5.731M |
| September 30, 2022 | -6.847M |
| June 30, 2022 | -7.443M |
| March 31, 2022 | -4.93M |
| December 31, 2021 | -4.304M |
| September 30, 2021 | -5.716M |
| June 30, 2021 | -6.842M |
| March 31, 2021 | -10.19M |
| December 31, 2020 | -11.99M |
| September 30, 2020 | -4.618M |
| June 30, 2020 | -6.77M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.645M |
| December 31, 2019 | -9.868M |
| September 30, 2019 | -3.938M |
| June 30, 2019 | -5.485M |
| March 31, 2019 | -6.155M |
| December 31, 2018 | -5.652M |
| September 30, 2018 | -6.324M |
| June 30, 2018 | -4.788M |
| March 31, 2018 | -6.198M |
| December 31, 2017 | -7.534M |
| September 30, 2017 | -7.470M |
| June 30, 2017 | -5.099M |
| March 31, 2017 | -4.942M |
| December 31, 2016 | -4.290M |
| September 30, 2016 | -4.385M |
| June 30, 2016 | -3.780M |
| March 31, 2016 | -3.460M |
| December 31, 2015 | -3.660M |
| September 30, 2015 | -1.636M |
| June 30, 2015 | -4.696M |
| March 31, 2015 | -4.013M |
| December 31, 2014 | -4.072M |
| September 30, 2014 | -0.7128M |
| June 30, 2014 | -4.077M |
| March 31, 2014 | -2.117M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 9.262M |
| Can-Fite BioPharma Ltd. | -- |
| Eocene Ltd. | -2.723M |
| Revium Recovery, Inc. | -0.584M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.299M |
| Total Expenses (Quarterly) | 3.377M |
| EPS Diluted (Quarterly) | -0.6957 |
| Enterprise Value | 7.392M |
| Gross Profit Margin (Quarterly) | 53.41% |
| Profit Margin (Quarterly) | -1.48K% |
| Earnings Yield | -82.09% |
| Normalized Earnings Yield | -82.19 |